​
​

Addex Therapeutics Ownership 2024 | Who Owns Addex Therapeutics Now?

OverviewForecastRevenueFinancialsChartTranscripts

Institutional Ownership

6.21%

0

Institutional Holders

5.00

Addex Therapeutics Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
NEA MANAGEMENT COMPANY, LLC----180,000-100.00%-Dec 31, 2023
BAADER BANK AKTIENGESELLSCHAFT----19,203-100.00%-Dec 31, 2023
JANE STREET GROUP, LLC----10,578-100.00%-Dec 31, 2023
ARMISTICE CAPITAL, LLC----537,000-100.00%-Dec 31, 2023
UBS GROUP AG----74-100.00%-Dec 31, 2023

Addex Therapeutics's largest institutional shareholder is NEA MANAGEMENT COMPANY, LLC, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
NEA MANAGEMENT COMPANY, LLC----180,000-100.00%-Dec 31, 2023
BAADER BANK AKTIENGESELLSCHAFT----19,203-100.00%-Dec 31, 2023
JANE STREET GROUP, LLC----10,578-100.00%-Dec 31, 2023
ARMISTICE CAPITAL, LLC----537,000-100.00%-Dec 31, 2023
UBS GROUP AG----74-100.00%-Dec 31, 2023

The largest Addex Therapeutics shareholder by % of total assets is NEA MANAGEMENT COMPANY, LLC. The company owns 0.00 shares of Addex Therapeutics (ADXN), representing 0.00% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
UBS GROUP AG----74-100.00%-Dec 31, 2023
JANE STREET GROUP, LLC----10,578-100.00%-Dec 31, 2023
BAADER BANK AKTIENGESELLSCHAFT----19,203-100.00%-Dec 31, 2023
NEA MANAGEMENT COMPANY, LLC----180,000-100.00%-Dec 31, 2023
ARMISTICE CAPITAL, LLC----537,000-100.00%-Dec 31, 2023

As of Dec 31 2023, Addex Therapeutics's largest institutional buyer is UBS GROUP AG. The company purchased -74.00 stocks of ADXN, valued at -.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ARMISTICE CAPITAL, LLC----537,000-100.00%-Dec 31, 2023
NEA MANAGEMENT COMPANY, LLC----180,000-100.00%-Dec 31, 2023
BAADER BANK AKTIENGESELLSCHAFT----19,203-100.00%-Dec 31, 2023
JANE STREET GROUP, LLC----10,578-100.00%-Dec 31, 2023
UBS GROUP AG----74-100.00%-Dec 31, 2023

As of Dec 31 2023, Addex Therapeutics's biggest institutional seller is ARMISTICE CAPITAL, LLC. The company sold -0.54M shares of ADXN, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ARMISTICE CAPITAL, LLC----537,000-100.00%-Dec 31, 2023
NEA MANAGEMENT COMPANY, LLC----180,000-100.00%-Dec 31, 2023
BAADER BANK AKTIENGESELLSCHAFT----19,203-100.00%-Dec 31, 2023
JANE STREET GROUP, LLC----10,578-100.00%-Dec 31, 2023
UBS GROUP AG----74-100.00%-Dec 31, 2023

Addex Therapeutics's largest sold out institutional shareholder by shares sold is ARMISTICE CAPITAL, LLC, sold -0.54M shares, valued at -, as of undefined.

Addex Therapeutics Institutional Ownership Trends

Institutional Holdings Trend

DateHoldingsChange %
30 Sep, 23566.67%
30 Jun, 233-57.14%
31 Mar, 237-
31 Dec, 227-22.22%
30 Sep, 22980.00%
30 Jun, 225-
31 Mar, 225-
31 Dec, 21525.00%
30 Sep, 214-
30 Jun, 21433.33%
31 Mar, 213-
31 Dec, 20350.00%
30 Sep, 202100.00%
30 Jun, 201-
31 Mar, 201-

As of 30 Sep 23, 5 institutions are holding Addex Therapeutics's shares, representing an increase of 66.67% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Sep, 23746,85561.09%
30 Jun, 23463,613-92.19%
31 Mar, 235,939,200367.32%
31 Dec, 221,270,898-79.24%
30 Sep, 226,122,606377.00%
30 Jun, 221,283,55320.31%
31 Mar, 221,066,834-5.46%
31 Dec, 211,128,476121.73%
30 Sep, 21508,9400.06%
30 Jun, 21508,65581.62%
31 Mar, 21280,0645.26%
31 Dec, 20266,0781335.00%
30 Sep, 2018,5426.45%
30 Jun, 2017,418-
31 Mar, 2017,418-

Addex Therapeutics (ADXN) has 746.86K shares outstanding as of 30 Sep 23, up 61.09% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Sep, 236.21%30.10%
30 Jun, 234.54%0.13%
31 Mar, 2358.18%20.43%
31 Dec, 2216.88%0.29%
30 Sep, 2276.88%18.20%
30 Jun, 2220.55%7.20%
31 Mar, 2216.89%4.29%
31 Dec, 2119.84%24.78%
30 Sep, 218.95%11.15%
30 Jun, 218.96%35.65%
31 Mar, 215.01%22.10%
31 Dec, 204.76%2740.44%
30 Sep, 200.42%271.45%
30 Jun, 200.39%253.97%
31 Mar, 200.39%-

As of 30 Sep 23, Addex Therapeutics is held by 6.21% institutional shareholders, representing a 30.10% growth compared to 30 Jun 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Sep, 23350.00%
30 Jun, 232-60.00%
31 Mar, 235-
31 Dec, 225-28.57%
30 Sep, 227133.33%
30 Jun, 223-
31 Mar, 22--100.00%
31 Dec, 212100.00%
30 Sep, 211-66.67%
30 Jun, 21350.00%
31 Mar, 212-
31 Dec, 202100.00%
30 Sep, 201-
30 Jun, 20--100.00%
31 Mar, 201-

3 institutional shareholders have increased their position in ADXN stock as of 30 Sep 23 compared to 2 in the previous quarter (a 50.00% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Sep, 231-
30 Jun, 231-50.00%
31 Mar, 232-
31 Dec, 222100.00%
30 Sep, 221-
30 Jun, 221-50.00%
31 Mar, 222-
31 Dec, 21--
30 Sep, 21--
30 Jun, 21--
31 Mar, 21--100.00%
31 Dec, 201-
30 Sep, 201-
30 Jun, 20--
31 Mar, 20--

1 institutional shareholders have reduced their position in ADXN stock as of 30 Sep 23 compared to 1 in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Sep, 23566.67%746,85561.09%6.21%30.10%350.00%1-
30 Jun, 233-57.14%463,613-92.19%4.54%0.13%2-60.00%1-50.00%
31 Mar, 237-5,939,200367.32%58.18%20.43%5-2-
31 Dec, 227-22.22%1,270,898-79.24%16.88%0.29%5-28.57%2100.00%
30 Sep, 22980.00%6,122,606377.00%76.88%18.20%7133.33%1-
30 Jun, 225-1,283,55320.31%20.55%7.20%3-1-50.00%
31 Mar, 225-1,066,834-5.46%16.89%4.29%--100.00%2-
31 Dec, 21525.00%1,128,476121.73%19.84%24.78%2100.00%--
30 Sep, 214-508,9400.06%8.95%11.15%1-66.67%--
30 Jun, 21433.33%508,65581.62%8.96%35.65%350.00%--
31 Mar, 213-280,0645.26%5.01%22.10%2---100.00%
31 Dec, 20350.00%266,0781335.00%4.76%2740.44%2100.00%1-
30 Sep, 202100.00%18,5426.45%0.42%271.45%1-1-
30 Jun, 201-17,418-0.39%253.97%--100.00%--
31 Mar, 201-17,418-0.39%-1---

Addex Therapeutics Peer Ownership

TickerCompany
DYAIDyadic International, Inc.
ACHLAchilles Therapeutics plc
LRMRLarimar Therapeutics, Inc.
ERYPPHAXIAM Therapeutics S.A.
KRONKronos Bio, Inc.
IPHAInnate Pharma S.A.
CYCNCyclerion Therapeutics, Inc.
SNGXSoligenix, Inc.
ATXIAvenue Therapeutics, Inc.

ADXN Ownership FAQ

Addex Therapeutics is owned by institutional shareholders (6.21%), insiders (0.00%), and public (93.79%). The largest institutional shareholder of Addex Therapeutics is NEA MANAGEMENT COMPANY, LLC (0% of total shares) and the top mutual fund owner is (0% of total shares).

Addex Therapeutics's major institutional shareholders are NEA MANAGEMENT COMPANY, LLC, BAADER BANK AKTIENGESELLSCHAFT, JANE STREET GROUP, LLC, ARMISTICE CAPITAL, LLC, and UBS GROUP AG. The top five shareholders own together 0% of the company's share outstanding.

As of Sep 2023, there are 5 institutional shareholders of Addex Therapeutics.

NEA MANAGEMENT COMPANY, LLC owns 0 shares of Addex Therapeutics, representing 0% of the company's total shares outstanding, valued at $0 (as of Dec 2023).

As of Dec 2023, BAADER BANK AKTIENGESELLSCHAFT holds 0 shares of Addex Therapeutics (ADXN), compromising 0% of the company, valued at $0.

JANE STREET GROUP, LLC is the third largest holder of Addex Therapeutics. The company owns 0 of the company's shares outstanding (worth $0).